A Th1 inducing adjuvant, MPL®, safely assists in reducing the length of a pollen allergy vaccination course

Authors
Category Primary study
JournalAlergologia e Inmunologia Clinica
Year 2002
This article has no abstract
Epistemonikos ID: 73f28dd922ac9a8c9d6e1ecebddee9c03116606c
First added on: Feb 03, 2025